This company is engaged in the development and manufacture of healthcare products. It was incorporated in 1946 and has its registered head office located in Kundl, Austria. It is one of the largest manufacturers of generic pharmaceuticals as well as pharmaceutical and biotechnological active ingredients. The company strives to become the world's leading supplier of low-cost quality medicines and make an important contribution to ensuring that people around the world can afford the best possible medical care. It develops, produces and markets around 1100 high-quality, low-cost pharmaceuticals in more than 160 countries - from standard generics to complex value-added products. Its product line includes bio-similars, inhalers, patches, injectables, and oral solids. The company operates several drug stores within the country. The company operates as a subsidiary of Novartis Group, is the second largest generics company in the world, offering a wide range of high-quality and cost-effective pharmaceutical products whose patent protection has expired.
The read only version of the questionnaire submitted to this company is publicly available: view questionnaire.